High-resolution, non-destructive imaging with micro-computed tomography (mCT) enables in situ monitoring of tissue engineered bone constructs. However, it remains controversial, if the locally imposed X-ray dose affects bone development and thus could influence the results. Here, we developed a model system for mCT monitoring of tissue engineered bone-like constructs. We examined the in vitro effects of high-resolution mCT imaging on the cellular level by using pre-osteoblastic MC3T3-E1 cells embedded into three-dimensional collagen type I matrices. We found no significantly reduced cell survival 2 h after irradiation with a dose of 1.9 Gy. However, 24 h post-irradiation, cell survival was significantly decreased by 15% compared to non-irradiated samples. The highest dose of 7.6 Gy decreased survival of the pre-osteoblastic MC3T3-E1 cells by around 40% at 2 days post-irradiation. No significant increase of alkaline phosphatase (ALP) activity at 2 days post-irradiation was found with a dose of 1.9 Gy. However, ALP activity was significantly decreased after 7 days. Using our model system, the results indicate that mCT imaging with doses as low as 1.9 Gy, which is required to obtain a reasonable image quality, can induce irreparable damages on the cellular level.
Introduction
In vitro engineering of functional tissue constructs has gained importance in the past decade as the shortage of organs and tissues for transplantation increased w21x, but also for safety and efficacy testing of new therapeutics w8, 12, 15x. So far, quality testing of engineered tissue constructs relied on destructive techniques including reverse transcription polymerase chain reaction to analyze gene expression or histology to assess organization and integrity of the tissue. Thus, monitoring over time and functional optimization in response to assessed changes in tissue morphology and functionality was not possible with these techniques. Other methods, such as magnetic resonance imaging or positron emission tomography, do not provide sufficient spatial resolution w10, 17x.
Micro-computed tomography (mCT) was shown to be useful as a non-destructive method in imaging three-dimensional (3D) bone microarchitecture at resolutions in the order of 10 mm in relatively short acquisition time (5-30 min) and at low cost w2, 3, 19x. In recent studies, mCT was used to monitor the development of 3D in vitro engineered bone-like tissues w4, 13, 14x, cartilage-like tissues w23x or skin-like layers w20x over time. However, one drawback of obtaining high-quality mCT images can be the locally deposed radiation dose and its potential effect on cell survival, cell functionality and cell development w11x.
Several studies have examined the effects of ionizing radiation on bone cells in a two-dimensional (2D) environment at doses up to 8 Gy w5, 6, 9x. Although the proliferation of MC3T3-E1 pre-osteoblastic cells and osteoblast-like cells from the rat calvarium was not affected by a radiation dose of 0.4 Gy, a dose of 4.0 Gy significantly decreased proliferation in all studies, and in some cases significantly altered alkaline phosphatase (ALP) activity, collagen production and vascular endothelial growth factor secretion as compared to non-irradiated control samples. However, irradiation effects on 3D tissue engineered constructs, which mimic native 3D tissue and organ structures better than 2D environments w8, 12x, are not fully understood. Specifically, the critical dose, which can maximally be deposited onto the constructs without inducing cellular damages, is not clear. Because there is a big difference between a flat layer of cells and a complex 3D tissue w1x, it is important to investigate the irradiation effect in 3D tissues.
The aim of this study was to assess this maximum dose.
We have developed a model system for mCT monitoring of 3D tissue engineered constructs and to elucidate effects of the ionizing radiation applied by mCT imaging on the cellular level by using MC3T3-E1 pre-osteoblastic cells embedded in 3D collagen type I matrices mimicking bone-like tissue w7, 16x. We hypothesized that the locally deposed X-ray dose by high-resolution mCT imaging can cause alterations on the cellular level in a dose-and time-dependent manner. This not only can affect the development of engineered 3D tissue constructs for clinical applications but also the results of pharmaceutical studies for testing new therapeutics.
Materials and methods

Dose measurement with thermoluminescent detectors
The radiation dose occurring with typical settings for mCT lower. The best spatial resolution (10% MTF) at 6 mm voxel size is specified by the manufacturer to be 10 mm. After irradiation, the TLDs were read out with a photo-multiplier using a standard heating protocol. For all cell experiments the medium resolution mode at 20 mm nominal resolution was used, but with a threefold increased integration time resulting in a calculated base dose of 1.9 Gy per measurement. To achieve the higher doses of 3.8, 5.7, and 7.6 Gy, the base measurement was repeated 2, 3, and 4 times, respectively. The total times for application of these radiation doses were 1.5 h, 3 h, 4.5 h, and 6 h, respectively. To examine potential differences in image quality, a bovine trabecular bone sample was scanned with mCT in four different modes: in standard resolution mode at 30 mm and 16 mm nominal resolution, as well as in high resolution mode at 15 mm and 8 mm nominal resolution.
Culture of pre-osteoblastic MC3T3-E1 cells
A MC3T3-E1 subclone 24 (LGC Promochem Sarl, Molsheim Cedex, France) was cultured between passage 6-10 in alpha-modified minimum essential medium containing 10% fetal bovine serum (both Invitrogen, Basel, Switzerland), 1 mg/ml bone morphogenic protein-2 produced as previously shown w22x, and 25 mmol 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Sigma-Aldrich, Buchs, Switzerland).
Preparation of 3D collagen matrices
Collagen type I matrices (Vitrogen 100, Cohesion, Palo Alto, CA, USA) of 2 mg/ml were used. Matrix formation was initiated by raising the pH to physiological conditions (pH 7.4) by adding 0.1 M NaOH to the collagen solution. To ensure homogeneous cell encapsulation, the matrices were presolidified at 378C for 5 min prior to the addition of 500,000 cells/ml collagen I. Matrices with a volume of 30 ml were then filled into sterilized (70% ethanol, exposure to UV light) PMMA sample holders with a capacity of 35 ml and incubated for 30 min at 378C to solidify. The sample holders containing the 3D cell cultures were then kept in 1 ml medium in a well of a 24-well plate under standard cell culture conditions.
Irradiation with mCT
A high-resolution micro-computed tomography system (mCT40, Scanco Medical AG, Brüttisellen, Switzerland) was used to apply the ionizing radiation to the cells embedded in the 3D collagen type I matrices. The system was operated in all cell experiments at a peak voltage of 50 kV with an integration time of 300 ms at a nominal resolution of 20 mm.
The absolute dose delivered to the samples was assessed in an independent experiment using TLDs. In all experiments, cultured MC3T3-E1 cells embedded in 3D collagen type I matrices were exposed to radiation 24 h after seeding into the collagen matrix. For cell survival experiments, cells were irradiated with doses of 1.9, 3.8, 5.7, and 7.6 Gy. For DNA and ALP assays, a dose of 1.9 Gy was applied. Control samples were placed inside the mCT, shielded with a lead cylinder against potential irradiation. Temperature effects on cell survival and ALP expression during a mCT run can thus be excluded. Survival experiments as well as ALP/DNA experiments were all compared with this mCT control.
Cell survival after mCT irradiation
Cell survival after mCT irradiation was determined with a live/dead cytotoxicity kit (Molecular Probes, Eugene, OR, USA). This assay was performed 2 h and 24 h post-irradiation (per dose, and per time point: n samples s3, n control s9). The samples were washed in phosphate buffered saline (PBS, Sigma Aldrich, Basel, Switzerland) and stained for 45 min with 200 ml live/dead staining solution (4 mM ethidium homodimer-1, 2 mM calceinAM in PBS). The samples were then washed in PBS and fixed in 4% glutaraldehyde. Epifluorescence images were taken at five randomly selected locations (area of ;2=1 mm 2 ) within the matrix by using a fluorescence microscope (Zeiss Axiovert 135, Feldbach, Switzerland) and the fluorescence for calceinAM was determined with an excitation wavelength of 495 nm and an emission wavelength of 515 nm. For ethidium homodimer-1, an excitation wavelength of 495 nm and an emission wave-length of 635 nm were used, respectively. The number of surviving cells per total number of cells (live cells plus dead cells, between 30 and 100 cells in total, per location) was determined by manual counting. The cell numbers of the irradiated samples were normalized to the non-irradiated control samples, which were placed into the mCT with lead shielding.
ALP activity assay
Each sample was homogenized in 300 ml lysis solution (0.2% v/v Triton X-100 in 0.56 M 2-amino-methyl-1-propanol, pH 10.0). Total number of samples/controls per time point: n samples s10, n control s10. From each sample an aliquot was used to determine ALP activity. Briefly, 150 ml of the lysed cell suspension was mixed with 20 ml of p-nitrophenyl phosphate solution (74 mg/ml in 0.56 M 2-amino-methyl-1-propanol, pH 10.0) and incubated at 378C for 30 min. The reaction was stopped by addition of 85 ml 2 N NaOH. The ALP activity was then determined by measuring the absorbance at 405 nm with a spectrometer (Spectronic Genesys 2PC, Thermo Fisher Scientific, Milford, MA, USA).
DNA determination assay
To determine the DNA content per gel, 30 ml of the lysed cell suspension was neutralized by addition of 270 ml TE buffer (100 mM Tris-HCl, pH 7.6, 1 mM EDTA) and centrifuged for 15 min at 11,000=g. Then, 270 ml of sample or DNA standard was mixed with 270 ml Pico Green (Molecular Probes, Eugene, OR, USA) which was diluted 1:200 in TE buffer. Total number of samples/controls per time point: n samples s10, n control s10. Fluorescence was measured in triplicate using a spectrometer (Synergy HT, BioTek Instruments, Inc., Winooski, VT, USA) at 520 nm (excitation wavelength: 480 nm).
Statistical analysis
The cell survival experiments were performed at different doses and are shown as mean values"standard deviation (total number of samples: per dose and per time point: n samples s3, n control s9). Each sample point was normalized by its corresponding control sample. Comparative analysis was performed with a two-way analysis of variance. To test for significant differences between the dose groups, a pairwise t-test was applied with Holm correction for multiple testing, for both the 2 h and 24 h time groups. To examine significant differences between the 2 h and 24 h time groups within a dose group, we used the Student t-test. Significant differences were accepted for p-0.05.
The results of the DNA and ALP tests were statistically analyzed using a pairwise Wilcoxon rank sum test with Holm correction for multiple testing. Total number of samples/controls per time point: n samples s10, n control s10. Differences between two data sets were considered statistically significant if p-0.05. For all statistical analyses we used ''R'', a language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria).
Results
Dose measurement and image quality
To investigate the relation between applied dose and image quality, a bovine trabecular bone sample was scanned with mCT applying the doses 0.150 Gy and 0.528 Gy in the standard resolution mode, and 0.458 Gy and 1.980 Gy in the high resolution mode ( Figure 1A-C) . Better image quality (higher resolution) resulted from higher applied doses (Figure 1A) . The gray level images show a better quality by increasing the resolution from 30 to 8 mm, and with changing the imaging mode from standard to high resolution. In addition, the binary images in high resolution mode were found to better display the ''real'' trabecular structure as compared to the binary images in the standard resolution mode. However, the differences are relatively small and depending on the application a low resolution mode can yield reasonable results at an acceptable dose. We show that the relation between dose and image quality, here represented as nominal resolution, can be modeled as a power law with exponents 1.74, 1.76, and 2.03 for the standard, medium, and high resolution mode, respectively ( Figure 1B,C) .
Cell survival after mCT imaging is dose-and time-dependent
To examine the effects of high-resolution mCT imaging on a cellular level, we first evaluated the survival rate 2 h and 24 h post-irradiation, with doses of 1.9, 3.8, 5.7, and 7.6 Gy, respectively, using custom-made PMMA sample holders. We found no significant increase in cell death for a dose of 1.9 Gy immediately (2 h) after irradiation as compared to the non-irradiated control group. However, 24 h post-irradiation, cell survival was significantly decreased by 15% over the control group. Doses after exposure to 3.8 Gy and 5.7 Gy resulted in survival rates of around 80%. Although we did not find a significant decrease in cell survival after exposure to 3.8 Gy between 2 h and 24 h post-irradiation, we demonstrate a significant decrease after exposure to 5.7 Gy by 15%. The highest dose of 7.6 Gy decreased the survival rate of the cells by around 40% 24 h post-irradiation as compared to non-irradiated control samples. Nevertheless, no significant difference between 2 h and 24 h post-irradiation was observed for this highest dose.
Time-dependent decrease of ALP activity per cell
To further investigate the cellular effects of high-resolution mCT imaging, we applied a dose of 1.9 Gy and analyzed ALP activity. When ALP activity was normalized with the DNA content of the same sample, we found no significant increase in ALP activity 2 days post-irradiation, but a significant decrease to approximately 60% at 7 days (Figure 2) .
Discussion
This is one of the first studies investigating the effect of ionizing radiation of high-resolution mCT measurements on The relation between dose and image quality (here given as nominal resolution) can be modeled as a power law with exponents 1.74, 1.76, and 2.03, for standard, medium and high resolution mode, respectively. (C) Radiation dose in function of the imaging mode. For all cell experiments the medium resolution mode at 20 mm nominal resolution was used, but with a threefold integration time resulting in a calculated base dose of 1.9 Gy per measurement. To achieve the higher doses of 3.8, 5.7, and 7.6 Gy, the base measurement was repeated 2, 3, and 4 times, respectively.
Figure 2
Time-dependent decrease of ALP activity after exposure to 1.9 Gy radiation dose. Although no significant alteration in the 2 day post-irradiation group was found, the ALP activity was significantly decreased by 60% at 7 days post-irradiation. In these box plots, the box represents/contains 50% of the data, and the whiskers show the data range excluding extreme values that are shown as single data points. Differences between two data sets were considered statistically significant if p-0.05 and are indicated in the Figure by a star. a cellular level by using a 3D tissue-like model system. Using our model system, the results indicate that mCT imaging with doses as low as 1.9 Gy, which is required to obtain a reasonable image quality, can induce irreparable damages on the cellular level.
The dose applied by a mCT measurement depends on the imaging mode and scanner settings, which are adapted to the features of interest. For instance, if bone volume density is of interest, a relatively low image quality could provide sufficiently good results. However, to capture alterations on the bone surface, a relatively good image quality with high resolution is required, which could be needed to expose the tissue to doses of 2 Gy or even higher. In such cases, the applied dose is not negligible and could result in potential side effects on the cellular level as demonstrated in Figures  2 and 3 .
Our results indicate that the effects of ionizing radiation on survival of the pre-osteoblastic MC3T3-E1 cells are different in our 3D model system with collagen type I matrices mimicking natural bone-like tissue as compared to 2D culture plates. We show considerably higher survival rates when similar doses are applied as previously reported for 2D studies ( Figure 3A,B) . For instance, it was demonstrated that osteoblast-like cells from the calvarium of newborn rats survived only by 60%, 35%, and less than 5% on a 2D surface when 2, 4, and 6 Gy, respectively, were applied to the culture w5x. The reason for this difference is unclear. We speculate that the 3D organization of the cells mimicking a more natural tissue-like environment than a 2D culture could have a protective effect, but also supports repair mechanisms more efficiently after irradiation damage. In addition, shielding effects of the PMMA sample holder might not be totally excluded. (A) Representative image of pre-osteoblastic cells in 3D collagen matrices 24 h post-irradiation. (B) Dose-and time-dependent survival 2 h and 24 h after irradiation as assessed by quantifying live/dead cell staining. At a dose of 2 Gy, which is commonly applied for in vitro and in vivo imaging, the fraction of surviving cells 24 h after irradiation is significantly lower than at 2 h. The highest dose applied (8 Gy) still resulted in survival of )60% both at 2 h and 24 h after irradiation. The survival rates at each dose were normalized by the survival rates of the control samples and are shown as mean values"standard deviation (n samples s3, n controls s9; images were taken at five randomly selected/representative locations within the matrix). Significant differences were accepted if p-0.05. * Indicates significantly different data between 2 h and 24 h.
Expression of ALP activity is a relevant marker in the early differentiation process of MC3T3-E1 pre-osteoblastic cells towards mature osteoblasts as it is upregulated with proceeding maturation w18x. We show here a time-dependent decrease of ALP activity after exposure to radiation ( Figure  2 ). Although no significant alteration was found 2 days postirradiation, the ALP activity was significantly decreased at 7 days by around 60%. We speculate that differentiation and maturation processes could be inhibited after irradiation. However, it is not clear by which mechanisms the ALP activity is influenced by irradiation. It could be as a result of altered cytokine expression profiles, by the irradiation directly or by combined processes w6x. Other authors found inhibition of differentiation, when exposing mature osteoblasts in a 2D environment to 4 Gy doses. In a study by Hagenmüller et al., ALP activity normalized to the DNA content was shown to be decreased by around 20% after 3 days of irradiation, around 60% after 6 days, and around 70% after 9 days. However, a study using 3D scaffolds prepared from silk fibroin and human mesenchymal stem cells did not demonstrate alterations in ALP activity after repeated high-resolution mCT imaging over a period of 28 days w13x. The reasons for these controversial results on the ALP activity could include different study designs including different cell types, radiation doses, the different times between the mCT imaging and the ALP activity assays, which can allow DNA repair processes in some cases, as well as the different biophysical and biochemical properties of the 3D scaffolds used in the respective studies.
The direct transfer of the results obtained in this study into in vivo experiments might not be possible; however, the in vitro model system applied here allows conclusions for in vitro tissue engineered constructs or bone chambers (i.e., critical dose). The critical dose for in vivo applications needs to be assessed with the respective in vivo models, specifically the effects on bone tissue growth, healing, and turnover. Potential immune reactions, vascularization of the tissue, and potential shielding effects of the surrounding tissue can affect the critical dose in vivo.
Conclusion
We have established a model system allowing the monitoring of 3D tissue engineered constructs using mCT imaging. Our results indicate significant impairments on the cellular level after imaging with high-resolution mCT in a time-and dosedependent manner. Results from this study indicate that imaging with high-resolution mCT with doses as low as 1.9 Gy, which is required to obtain a reasonable image quality, can yield irreparable damages on the cellular level.
It is therefore recommended to use the lowest resolution necessary in monitoring studies of bone chambers and 3D tissue engineered bone-like constructs. Future studies could include other cells such as mesenchymal cells present in bone tissue and/or different scaffolds, as well as longitudinal monitoring. Longitudinal animal studies could be performed to assess a critical in vivo dose to avoid potential damages on the cellular level.
